Sun. May 28th, 2023

New Delhi (India), January 31: BSE (560961) & NSE (VIKASECO) listed Vikas Ecotech Ltd an emerging player in the global arena of the high-end specialty chemicals players, offering eco-friendly and technologically superior products to the world, has announced that on persistence and support extended by the promoters of the Company, it has initiated 2nd Phase of the Debt Reduction Program, wherein overall bank debt shall further get reduced by another 20% from the peak exposure. Rs. 100 million has been paid back already and another trench of Rs. 120 million has been paid to reduce its’ bank debt, in the Phase-II of Debt-Reduction Program, making it Rs. 220 million bank-debt repaid of the Rs. 350 million bank debt repayment envisioned for the current fiscal.

After completion of both these phases, bank debt shall get reduced by approx. 40% from the peak exposure, paving the way towards becoming a ‘ZERO debt company’ in the next financial year i.e. 2022-23.

Further, promoters of the Company have intended to get their financial assistance/unsecured loans, provided for debt reduction program, converted into equity at the appropriate stage after obtaining statutory approvals.

Recently, Vikas Ecotech had informed exchanges that it has been diversifying to newer markets with innovative products.

As a measure of backward integration, the Company has commissioned a Steel Pipe Fittings plant, which after trial production, went into commercial production almost 2 months ahead of schedule.

With increasing economic activities and governments thrust on infrastructure development, there is a huge demand of fittings by all major steel tube manufacturers like APL Apollo, Jindal, Hi-tech, etc. and they prefer sourcing from the vendors who has

inhouse steel tube fitting manufacturing facilities.

Considering it as a long-term opportunity, which not only enhances the company’s revenues, product basket, profitability but also mitigates concentration risk, the company has successfully bagged commercial-scale orders. Since the production of fittings and their supplies are much ahead of their scheduled targets, Vikas is expecting a good revenue contribution of this newly added business segment.

The company has been most recently empanelled as an approved vendor with the U.P. State Horticultural Co-Operative Marketing Federation (HOFED) a UP Govt. Enterprise.

Its first of its kind of empanelment for Vikas Ecotech that too along-side other industry conglomerates like Supreme Industries, Advance Biocare, Stellar Polyplast etc.

Enhancements in Intellectual Property: Successful registration of patent for use of Nano CaCO3 in Plastic & Rubber Compounds The company’s ultra modern latest state of art, R&D laboratory undertook research  for Nano Composites and their use in the plastic and rubber industry, the company has filed a patent for the use of Nano Calcium Carbonate (CaCO3) as a multi role additive and modifier.

By dsprime

18 thoughts on “Vikas Ecotech Board Paybacks 2 trenches of Debt under its Debt Reduction Program Phase-II, Aiming to Enter Zero Debt Regime”
  1. 478550 157631This kind of publish appears to get yourself a great deal of visitors. How will you acquire traffic to that? It provides a fantastic distinctive twist upon issues. I guess having something traditional or possibly substantial to give information on will be the central aspect. 214151

  2. 829052 947414hi!,I like your writing so a good deal! share we communicate far far more about your post on AOL? I want a specialist on this area to solve my difficulty. Could be thats you! Looking forward to see you. 706984

  3. 932933 608600Official NFL jerseys, NHL jerseys, Pro and replica jerseys customized with Any Name / Number in Pro-Stitched Tackle Twill. All NHL teams, full range of styles and apparel. Signed NFL NHL player jerseys and custom team hockey and football uniforms 860513

  4. 435733 832628Hey, you used to write great, but the last several posts have been kinda boring I miss your tremendous writings. Past few posts are just slightly bit out of track! come on! 494505

  5. 90 Y chelated In vivo Cilengitide HBT 3477 cell xenografted mice Increased efficacy compared to radiotherapy cilengitide alone 131 I In vivo Humanized anti Lewis Y MCF 7 xenografted mouse Significant tumor growth inhibition compared to control radiolabeled antibody 131 I In vivo 131 I IgG2a rat MDA MB 361 xenograft Tumor growth inhibition for more than 24 days 111 In 90 Y Phase I IgG1 BrE3 Metastatic breast cancer patients Risk of developing HAMA response 131 I Pilot clinical study 131 I IgG1 ChL6 Metastatic breast cancer patients Partial response achieved with the development of thrombocytopenia and granulocytopenia cialis coupon Comparative evaluation of enalapril and losartan in pharmacological correction of experimental osteoporosis and fractures of its background

Leave a Reply

Your email address will not be published.